Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,318 papers from all fields of science
Search
Sign In
Create Free Account
Anticancer Drugs - Consent type
Known as:
Anticancer Drugs
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Cytotoxic Effects of Phosphonate-Functionalized Mesoporous Silica Nanoparticles.
N. Menon
,
D. Leong
ACS Applied Materials and Interfaces
2016
Corpus ID: 206412441
In this work, we synthesized pristine mesoporous silica nanoparticles (MSN) and functionalized these with phosphonate groups (MSN…
Expand
Review
2016
Review
2016
Current situation and future usage of anticancer drug databases
Hongzhi Wang
,
Yuanyuan Yin
,
+5 authors
L. Fu
Apoptosis
2016
Corpus ID: 17568818
Cancer is a deadly disease with increasing incidence and mortality rates and affects the life quality of millions of people per…
Expand
2016
2016
The leaching behavior of cyclophosphamide and ifosfamide from soil in the presence of co-contaminant--Mixture sorption approach.
Katarzyna Mioduszewska
,
J. Maszkowska
,
+5 authors
P. Stepnowski
Science of the Total Environment
2016
Corpus ID: 21988842
Review
2010
Review
2010
An onco-informatics database for anticancer drug interactions with complementary and alternative medicines used in cancer treatment and supportive care: an overview of the OncoRx project
K. Yap
,
En Yi Kuo
,
Jonathan Lee
,
W. Chui
,
A. Chan
Supportive Care in Cancer
2010
Corpus ID: 6590788
PurposeCancer patients are at high risk of manifesting interactions from use of anticancer drugs (ACDs) and complementary and…
Expand
2010
2010
Drug-Drug Interactions between Oral Antiepileptics and Oral Anticancer Drugs: Implications to Clinicians
Y. T. Cheung
,
K. Yap
,
W. Chui
,
A. Chan
European Neurology
2010
Corpus ID: 27924523
Background: Existing research has suggested that there can be potential drug-drug interaction (DDI) between antiepileptic drugs…
Expand
2008
2008
Distinguishing compounds with anticancer activity by ANN using inductive QSAR descriptors
Kunal Jaiswal
,
P. Naik
Bioinformation
2008
Corpus ID: 13194487
This article describes a method developed for predicting anticancer/non-anticancer drugs using artificial neural network (ANN…
Expand
Review
2006
Review
2006
Fluorescence studies of anti-cancer drugs--analytical and biomedical applications.
J. Aaron
,
S. Trajkovska
Current Drug Targets
2006
Corpus ID: 25102115
The fluorescence properties of anticancer drugs (ACDs), including steady-state native fluorescence, time-resolved fluorescence…
Expand
2005
2005
Prescription Errors with Cytotoxic Drugs and the Inadequacy of Existing Classifications
Cyril Slama
,
J. Jérome
,
C. Jacquot
,
B. Bonan
Pharmacy World & Science
2005
Corpus ID: 23972137
Objective: To quantify the amount of potential prescription errors for anticancer drugs in order to improve the quality of care…
Expand
1999
1999
Treatment of poor prognosis AML patients using PSC833 (valspodar) plus mitoxantrone, etoposide, and cytarabine (PSC-MEC).
R. Advani
,
G. Visani
,
+14 authors
P. Greenberg
Advances in Experimental Medicine and Biology
1999
Corpus ID: 29453523
The failure of convenional chemotherapy in relapsed or refractory and other poor risk AML patients has been linked to expression…
Expand
Review
1997
Review
1997
[SDZ PSC 833: a novel modulator of MDR].
A. Covelli
Tumori
1997
Corpus ID: 7567644
SDZ PSC 833 is a novel compound able to reverse the resistance to chemotherapy of cancer cells with the multidrug resistance (MDR…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required